PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,559,402 | +40805.7% | 382,310 | -65.9% | 0.01% | -66.7% |
| Q1 2023 | $25,814 | +69.6% | 1,122,342 | -19.6% | 0.02% | +87.5% |
| Q4 2022 | $15,224 | -99.1% | 1,395,389 | +604.7% | 0.01% | +700.0% |
| Q3 2022 | $1,669,000 | -81.2% | 198,022 | -82.3% | 0.00% | -80.0% |
| Q2 2022 | $8,855,000 | -23.7% | 1,119,528 | +128.4% | 0.01% | -16.7% |
| Q1 2022 | $11,606,000 | -19.4% | 490,115 | +16.4% | 0.01% | -14.3% |
| Q4 2021 | $14,401,000 | +39.4% | 421,073 | -27.8% | 0.01% | 0.0% |
| Q3 2021 | $10,328,000 | +1390.3% | 582,871 | +3675.1% | 0.01% | – |
| Q2 2021 | $693,000 | +145.7% | 15,440 | +41.8% | 0.00% | – |
| Q1 2021 | $282,000 | -38.6% | 10,892 | -52.2% | 0.00% | – |
| Q4 2020 | $459,000 | -93.2% | 22,766 | -94.1% | 0.00% | -100.0% |
| Q2 2020 | $6,785,000 | +180.8% | 384,205 | +12.3% | 0.01% | +80.0% |
| Q1 2020 | $2,416,000 | -59.5% | 342,175 | -59.6% | 0.01% | -28.6% |
| Q4 2019 | $5,971,000 | -40.7% | 846,994 | +1.1% | 0.01% | -56.2% |
| Q3 2019 | $10,063,000 | +2.5% | 837,892 | +3.3% | 0.02% | +6.7% |
| Q2 2019 | $9,822,000 | -12.5% | 811,066 | -9.2% | 0.02% | -11.8% |
| Q1 2019 | $11,227,000 | +141.7% | 893,155 | +29.4% | 0.02% | +142.9% |
| Q4 2018 | $4,645,000 | -56.3% | 690,151 | -33.2% | 0.01% | -46.2% |
| Q3 2018 | $10,638,000 | +593.5% | 1,033,798 | +352.9% | 0.01% | +550.0% |
| Q2 2018 | $1,534,000 | -44.3% | 228,281 | -28.8% | 0.00% | -50.0% |
| Q1 2018 | $2,755,000 | -31.3% | 320,739 | +66.4% | 0.00% | -33.3% |
| Q4 2017 | $4,009,000 | +65.2% | 192,730 | +40.3% | 0.01% | +50.0% |
| Q3 2017 | $2,427,000 | +6.4% | 137,352 | -31.9% | 0.00% | 0.0% |
| Q2 2017 | $2,281,000 | – | 201,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |